BRCA2 antibody (AA 2336-2478)
Quick Overview for BRCA2 antibody (AA 2336-2478) (ABIN7468065)
Target
See all BRCA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 2336-2478
-
Cross-Reactivity
- Human
-
Purification
- Protein G purified
-
Immunogen
- Amino acids 2336-2478 of human BRCA2 expressed in E. coli. BRCA2-P400.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Do not boil samples for longer than two minutes. For WB: Use at a concentration of 1-5 μg/mL. Predicted molecular weight: 380 kDa. Optimal dilutions/concentrations should be determined by the reseracher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, No Preservative
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Alternative Name
- BRCA2 DNA repair associated
-
Background
-
Synonyms: BRCA2 DNA repair associated , BRCC2 , BROVCA2 , FACD , FAD , FAD1 , FANCD , FANCD1 , GLM3 , PNCA2 , XRCC11
Background: Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, Dec 2008]
-
Molecular Weight
- 384 kDa
-
Gene ID
- 675
-
UniProt
- P51587
-
Pathways
- DNA Damage Repair, M Phase, Maintenance of Protein Location
Target
-